| RS2468126249 |
SCN2A
|
Health Risk |
Likely pathogenic |
Episodic ataxia, type 9 |
| RS2468126385 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468126508 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468126622 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2468126666 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468126672 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468126706 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468126735 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468129330 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468129385 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468129580 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS2468129590 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468129607 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468129644 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468129656 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS2468129774 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS2468129879 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468130036 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468130177 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468130270 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2468130287 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468130308 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468131337 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2468131662 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468131676 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468131781 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468131950 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468132693 |
SCN1A
|
Health Risk |
Pathogenic |
SCN1A Seizure Disorders, SCN1A Seizure Disorders |
| RS2468132935 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468133156 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468134625 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2468135466 |
TTN
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS2468135575 |
TTN
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS2468137966 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2468138852 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS2468138958 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata, Rhizomelic chondrodysplasia punctata |
| RS2468140499 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2468140689 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2468141450 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468141601 |
SCN1A
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2468142195 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468144479 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS2468145475 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2468149284 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468149360 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468149427 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468149509 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468149512 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS2468149587 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS2468149606 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2468149619 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468149925 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS2468150040 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2468150101 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2468150164 |
SCN2A
|
Health Risk |
Pathogenic |
Episodic ataxia, type 9 |
| RS2468150265 |
SCN2A
|
Health Risk |
Pathogenic |
Episodic ataxia, type 9 |
| RS2468150457 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2468151030 |
MAP3K20
|
Health Risk |
Pathogenic |
— |
| RS2468151787 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468152107 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468152727 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468153527 |
SCN9A
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2468153767 |
TTN
|
Health Risk |
Likely pathogenic |
TTN-related disorder, TTN-related disorder |
| RS2468153773 |
HOXD13
|
Health Risk |
Pathogenic |
— |
| RS2468153827 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2468154010 |
TTN
|
Health Risk |
Likely pathogenic |
TTN-related disorder, Dilated cardiomyopathy 1G |
| RS2468154288 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468154852 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2468155045 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS2468156232 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2468156389 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468156577 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468156607 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468156828 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2468157284 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468157327 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468157518 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468157631 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468157758 |
SCN2A
|
Health Risk |
Likely pathogenic |
Episodic ataxia, type 9 |
| RS2468157766 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468157815 |
SCN2A
|
Health Risk |
Likely pathogenic |
unclassified developmental and epileptic encephalopathy, unclassified developmental and epileptic encephalopathy |
| RS2468158024 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468158032 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468158264 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2468158340 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468158346 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2468158869 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468158980 |
SCN2A
|
Health Risk |
Likely pathogenic |
benign sporadic infantile epilepsy, benign sporadic infantile epilepsy |
| RS2468159089 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS2468159200 |
SCN2A
|
Health Risk |
Likely pathogenic |
SCN2A-related disorder, SCN2A-related disorder |
| RS2468159814 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2468159922 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2468161838 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2468164977 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468165346 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2468165481 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2468165774 |
ITGA6
|
Health Risk |
Pathogenic |
— |
| RS2468166430 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2468168693 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2468169093 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |